XML 54 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Statement Details - Accrued Expenses and Other Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Financial Statement Details [Abstract]    
Accrued professional and service fees $ 7,668 $ 3,943
Accrued dissenting shares (Note 8) 6,769 6,335
Accrued bonus 5,288 4,121
Accrued preclinical and clinical trial costs 4,339 2,444
Accrued research and development costs 4,002 392
Accrued compensation 3,891 2,777
Financing obligation - current portion 1,421 757
Accrued contingent consideration payable 856 786
Accrued laboratory equipment and supplies 641 640
Accrued capital expenditures 337 0
Deferred revenue 270 162
Accrued franchise, sales, use and property taxes 103 200
Accrued other 1,186 928
Accrued expenses and other liabilities $ 36,771 $ 23,485